Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055579/0806 | |
| Pages: | 6 |
| | Recorded: | 03/12/2021 | | |
| Attorney Dkt #: | 020871-9121-US02 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/12/2023
|
Application #:
|
17122745
|
Filing Dt:
|
12/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/07/2021
| | | | |
|
Title:
|
TREATMENT OF COGNITIVE AND MOOD SYMPTOMS IN NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISORDERS WITH ALPHA5-CONTAINING GABAA RECEPTOR AGONISTS
|
|
|
Assignee
|
|
|
|
|
| 1440 EAST NORTH AVENUE |
| MILWAUKEE, WISCONSIN 53202 |
|
|
Correspondence name and address
|
| |
MICHAEL BEST & FRIEDRICH LLP
|
| |
790 N. WATER STREET
|
| |
SUITE 2500
|
| |
MILWAUKEE, WI 53202
|
Search Results as of:
06/17/2024 12:00 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
